Gelezen, mooi stuk, positieve resultaten.
..."No serious adverse events were reported that were related to either ARCEX Therapy or study procedures in any of the 64 participants who were exposed to any procedures of the Up-LIFT trial (Table 3). A total of 238 adverse events occurred throughout the duration of the study (Table 3, Extended Data Table 3 and Supplementary Data 2). These adverse events were reported in 50 of the 64 individuals who were exposed to any aspect of the Up-LIFT trial procedures. Three of these 238 adverse events were considered serious due to hospitalization associated with the event yet were unrelated to ARCEX Therapy or study procedures. They included constipation, urinary tract infections and bladder stone. Forty-four non-serious adverse events were related to ARCEX Therapy and were reported in 17 of the 64 participants (Table 3). One of these 44 events was a severe adverse event, which was reported in one participant and was related to the occurrence of severe muscle spasms during one rehabilitation session within the ARCEX Therapy period, but it was unrelated to ARCEX Therapy because the stimulation was not turned on when these spasms occurred. There were no unexpected adverse events"...
Je zou wellicht iets van hartritmestoornissen verwachten, door die pulsjes;
maar dat is - vooralsnog - niet zo. Nu gaat dus een aantal revalidatieklinie-
ken in de VS met ARC-EX aan de slag.
Ik denk dat wanneer de studieresultaten over 'n periode van 'n maand of 6
worden bevestigd, de goedkeuring voor thuisgebruik slechts 'n formaliteit
zal zijn.
[/quote]